The improved prognosis of <i>FLT3</i>-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data
Not available.
Saved in:
Main Authors: | Matthew Schwede, Gladys Rodriguez, Vanessa E. Kennedy, Solomon Henry, Douglas Wood, Gabriel N. Mannis, Ravindra Majeti, Jonathan H. Chen, Eran Bendavid, Tian Yi Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ferrata Storti Foundation
2025-02-01
|
Series: | Haematologica |
Online Access: | https://haematologica.org/article/view/11934 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cost-effectiveness of tyrosine kinase inhibitor treatment strategies for chronic myeloid leukemia in South Africa
by: Rochelle Woudberg, et al.
Published: (2025-01-01) -
Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases
by: Nozomi Sasaki, et al.
Published: (2025-01-01) -
Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
by: Romane Joudinaud, et al.
Published: (2025-01-01) -
Frequency and Prognostic Relevance of FLT3 Mutations in Saudi Acute Myeloid Leukemia Patients
by: Ghaleb Elyamany, et al.
Published: (2014-01-01) -
Tyrosine Kinase Inhibitor-Induced Intracranial Artery Stenosis – A Rare Cause of TIA in a Patient of Chronic Myeloid Leukemia
by: Sumedh S Agrawal, et al.
Published: (2024-12-01)